Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future Prospects
Avineesh Singh(Guru Ghasidas Vishwavidyalaya), Harish Rajak(Guru Ghasidas Vishwavidyalaya), Vijay K. Patel(Guru Ghasidas Vishwavidyalaya), Preeti Patel(Indo Soviet Friendship College of Pharmacy), Surendra Jain(University Of Medicine 1 Yangon)
Cited by 41
Related Papers
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs
|Life|2023|209
Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention
|Pharmacological Reports|2021|145
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
|Drug Delivery and Translational Research|2024|141
Alternatives of Animal Models for Biomedical Research: a Comprehensive Review of Modern Approaches
|Stem Cell Reviews and Reports|2024|85
Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches
|European Journal of Medicinal Chemistry|2021|72